WPRIM Management System> DCMS> Blood Research> 2020> 55> 4

Volume: 55 Issue: 4

1. COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale Page:278—281
2. Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens:a single-center analysis Page:262—274
3. Outcomes of patients with essential thrombocythemia and unnoticed thrombocytosis prior to diagnosis Page:281—282
4. First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients Page:253—261
5. Safety and effectiveness of Rixubis in patients with hemophilia B:a real-world, prospective, postmarketing surveillance study in South Korea Page:246—252
6. Changing the frequency and spectra of chromosomal aberrations in Korean patients with acute leukemia in a tertiary care hospital Page:225—245
7. Mining of mortality-related findings in rare bleeding disorders:a retrospective study from two centers Page:213—216
8. Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey Page:206—212
9. Bone marrow involvement by primary oxalosis Page:192—192
10. Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era Page:217—224
11. Pulmonary embolism rate in patients infected with SARS-CoV-2 Page:275—278
12. Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes Page:200—205
13. Prognostic value of TNF-α-308 and IFN-γ-874 single nucleotide polymorphisms and their plasma levels in patients with aplastic anemia Page:193—199
14. The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19) Page:191—191
15. COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale Page:278—281
16. Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens:a single-center analysis Page:262—274
17. Outcomes of patients with essential thrombocythemia and unnoticed thrombocytosis prior to diagnosis Page:281—282
18. First report of the unique expression of RECAF (receptor for alfa feto-protein) in adult B-NHL/CLL patients Page:253—261
19. Safety and effectiveness of Rixubis in patients with hemophilia B:a real-world, prospective, postmarketing surveillance study in South Korea Page:246—252
20. Changing the frequency and spectra of chromosomal aberrations in Korean patients with acute leukemia in a tertiary care hospital Page:225—245
21. Mining of mortality-related findings in rare bleeding disorders:a retrospective study from two centers Page:213—216
22. Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey Page:206—212
23. Bone marrow involvement by primary oxalosis Page:192—192
24. Outcomes of pediatric acute myeloid leukemia patients with FLT3-ITD mutations in the pre-FLT3 inhibitor era Page:217—224
25. Pulmonary embolism rate in patients infected with SARS-CoV-2 Page:275—278
26. Radiotherapy for non-gastric intestinal versus gastric MALT lymphoma: a comparison of treatment outcomes Page:200—205
27. Prognostic value of TNF-α-308 and IFN-γ-874 single nucleotide polymorphisms and their plasma levels in patients with aplastic anemia Page:193—199
28. The detection of Howell-Jolly body-like inclusions in a case of coronavirus disease-2019 (COVID-19) Page:191—191

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.